{"paper_id":"a9b5a625-bc16-4086-8957-4d6dbf44239f","body_text":"Résumé\nL’endométriose est une maladie bénigne, très invalidante et fréquente, définie par la présence d’endomètre, épithélium et stroma, en situation ectopique. Sa physiopathologie, et celle des douleurs qui l’accompagnent, est mal connue. Les signes cliniques de cette pathologie hormonodépendante sont dysménorrhée, dyspareunie et douleur chronique. On distingue deux grands types d’endométriose: l’endométriose superficielle ou minime et les formes sévères ou infiltrantes. Même s’il n’existe pas de parallélisme anatomoclinique, on sait que les lésions infiltrantes sont plus souvent à l’origine de dyspareunie, de troubles digestifs ou urinaires associés. Le traitement est soit un traitement médical qui stoppe la maladie en induisant une aménorrhée, soit un traitement chirurgical qui consiste en une destruction ou une excision des lésions. Ce traitement chirurgical est le plus souvent réalisé par coelioscopie. Les indications respectives de ces deux traitements dépendent du type de lésion et des circonstances diagnostiques et cliniques.\nAbstract\nEndometriosis is a benign disease, very incapacitating and common disease that is characterised by the endometrium, epithelium and stroma existing in an ectopic presentation. The physiopathology of this disease and its associated painisnotwell known.The clinical symptomsof this hormone-dependent disease are dysmenorrhea, dyspareunia and chronic pain. There are two main types of endometriosis: superficial endometriosis and more severe forms of endometriosis. Although there are no anatomical and clinical similarities, deep lesions very often cause dyspareunia, and associated digestive or urinary disorders. Treatment is either medical, which stops the disease by inducing amenorrhea; or surgical, which involves destroying or excising the lesions. Surgery ismost commonly doneby laparoscopy. The respective indications for these two types of treatment depend on the lesion type and the diagnostic and clinical circumstances.\nRéférences\nAbbott J, Hawe J, Hunter D, et al. (2004) Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril 82: 878–884\nAgence françise de sécurité sanitaire des produits de santé (2007) Les traitements médicamenteux de l’endométriose (en dehors de l’adénomyose). J Obstet Gynecol Biol Reprod 36: 201–234\nAnaf V, Simon P, El Nakadi I, et al. (2000) Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 15: 1744–1750\nAnaf V, Simon P, El Nakadi I, et al. (2002) Hyperalgesia,nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 17: 1895–1900\nBalasch J, Creus M, Fabregues F, et al. (1996) Visible and non-visible endometriosis at laparoscopy in fertile andinfertilewomenand inpatients with chronic pelvic pain: a prospective study. Hum Reprod 11: 387–391\nBallard K, Lowton K, Wright J (2006) What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril 86: 1296–1301\nBarbieri RL (1992) Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 166: 740–745\nBelaisch J (2003) Endométriose génitale et traumatismes psychologiques. In: Endométriose. Paris, Edition Masson p. 157–167\nBergqvist A, Bergh T, Hogstrom L, et al. (1998) Effects of triptorelin versus placebo on the symptoms of endometriosis. Fertil Steril 69: 702–708\nBerkley K, Dmitrieva N, Curtis K, Papka RE (2004) Innervatrion of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA 101: 11094–11098\nCanis M (2007) L’endométriose est une maladie simple! J Gynecol Obstet Biol Reprod 36(2): 106–107\nCanis M, Mage G, Wattiez A, et al. (1992) Second-look laparoscopy after laparoscopic cystectomy of large ovarian endometriomas. Fertil Steril 58: 617–619\nDalal, R, Djakiew D (1997) Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol Cell Endocrinol 134: 15–22\nDawood MY, Khan-Dawood FS, Wilson L Jr. (1984) Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. AmJObstetGynecol 148: 391–395\nDiamond MP, Daniell JF, Feste J, et al. (1987) Adhesion reformation and de novo adhesion formation after reproductive pelvic surgery. Fertil Steril 47: 864–866\nDlugi AM, Miller JD, Knittle J (1990) Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double blind study. Lupron Study Group. Fertil Steril 54: 419–427\nEmmert-Buck MR, Bonner RF, Smith PD, et al. (1996) Laser capture microdissection. Science 274: 998–1001\nEskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24: 235–258\nEvers JL (1987) The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil Steril 47: 502–504\nFauconnier A, Chapron C (2005) Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 11: 595–606\nFauconnier A, Chapron C, Dubuisson JB, et al. (2002) Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 78: 719–726\nFernandez H, Donnadieu AC (2007) Adenomyosis J Gynecol Obstet Biol Reprod 36: 179–185\nFritel X (2007) Endometriosis anatomoclinical entities. J Gynecol Obstet Biol Reprod 36: 113–118\nGao X, Outley J, Botteman M, et al. (2006) Economic burden of endometriosis. Fertil Steril 86: 1561–1572\nGruppo Italiano per lo Studio dell’Endometriosi (2001) Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain. Hum Reprod 16: 2668–2671\nGuo SW, Wang Y (2006) The prevalence of endometriosis in women with chronic pelvic pain. Gynecol Obstet Invest 62: 121–130\nGuo SW, Wang Y (2006) Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women. Fertil Steril 86: 1584–1595\nHadfield R, Mardon H, Barlow D, Kennedy S (1996) Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod 11: 878–880\nHarada T, Iwabe T, Terakawa N (2001) Role of cytokines in endometriosis. Fertil Steril 76: 1–10\nHarrison RF, Barry-Kinsella C (2000) Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril 74: 24–30\nHorie S, Harada T, Mitsunari M, et al. (2005) Progesterone and progestational compounds attenuate tumor necrosis factor alphainduced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells. Fertil Steril 83: 1530–1535\nHoshiai H, et al. (1993) Old problems, potential explanations, and solutions: laparoscopic evaluation of the onset and progression of endometriosis. Am J Obstet Gynecol 169: 714–719\nIwabe T, Harada T, Sakamoto Y, et al. (2003) Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas. Fertil Steril 80: 300–304\nJamieson DJ, Steege JF (1996) The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 87: 55–58\nKao LC, Germeyer A, Tulac S, et al. (2003) Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144: 2870–2881\nKauppila A, Puolakka, Ylikorkala O (1979) Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 18: 655–661\nKoninckx PR, Meuleman C, Demeyere S, et al. (1991) Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 55: 759–765\nKraus J, Borner C, Giannini E, Hollt V (2003) The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 64: 876–884\nKress M, Reeh PW (1996) Chemical excitation and sensitization in nociceptors. In Cervero F and Belmonte C (Eds) Neurobiology of nociceptors. Oxford University Press Inc, New York, USA pp. 258–297\nLaufer MR, Sanfilippo J, Rose G (2003) Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol 16(3 Suppl): S3–11\nLorencatto C, Petta CA, Navarro MJ, et al. (2006) Depression in women with endometriosis with and without chronic pelvic pain. Acta Obstet Gynecol Scand 85: 88–92\nMahmood TA, Templeton A (1990) The impact of treatment on the natural history of endometriosis. Hum Reprod 5: 965–970\nMannion RJ, Costigan M, Decosterd I, et al. (1999) Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA 96: 9385–9390\nMartin DC, Ling FW (1999) Endometriosis and pain. Clin Obstet Gynecol 42: 664–686\nMatsuzaki S, Canis M, Darcha C, et al. (1999) Fibrogenesis in peritoneal endometriosis. A semi-quantitative analysis of type-I collagen. Gynecol Obstet Invest 47: 197–199\nMatsuzaki S, Canis M, Murakami T, et al. (2001) Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis. Fertil Steril 76: 712–716\nMatsuzaki S, Canis M, Pouly JL, et al. (2004) Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium. Fertil Steril 82: 1309–1315\nMatsuzaki S, Canis M, Pouly JL, et al. (2006) Relationship between delay of surgical diagnosis and severity of disease in patients with symptomatic deep infiltrating endometriosis. Fertil Steril 86: 1314–1316\nMatsuzaki S, Canis M, Pouly JL, et al. (2007) Both gonadotropinreleasing hormone agonist and continuous oral progestin treatments reduced expression levels of tyrosine kinase receptor B and mu opioid receptor in deep infiltrating endometriosis. Hum Reprod 22: 124–128\nMatsuzaki S, Canis M, Vaurs-Barriere C, et al. (2004) DNA micro array analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod 10: 719–728\nMatsuzaki S, Canis M, Vaurs-Barriere C, et al. (2005) DNA micro array analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. Fertil Steril 84(Suppl 2): 1180–1190\nMaubon A, Bazot M (2007) Imagerie de l’endométriose J Gynecol Obstet Biol Reprod 36: 129–134\nMeshsner S, Schwartz J, Thode J, et al. (2007) Growth-associated protein 43-positive sensory nerve fibers accompanied by immature vessels are located in or near peritoneal endometriotic lesions. Fertil Steril (in press)\nNisolle M, Paindaveine B, Bourdon A, et al. (1990) Histologic study of peritoneal endometriosis in infertile women. Fertil Steril 53: 984–988\nOral E, Olive DL, Arici A (1996) The peritoneal environment in endometriosis. Hum Reprod Update 2: 385–398\nPol O, Alameda F, Puig MM (2001) Inflammation enhances muopioid receptor transcription and expression in mice intestine. Mol Pharmacol 60: 894–899\nRevised American Society for Reproductive Medicine classification of endometriosis: 1996 Fertil Steril 1997 67: 817–821\nRipps BA, Martin DC (1992) Correlation of focal pelvic tenderness with implant dimension and stage of endometriosis. J Reprod Med 37: 620–624\nRoman H (2007) Prise en charge d’une endométriose douloureuse. J Gynecol Obstet Biol Reprod 36: 141–150\nSakamoto Y, Harada T, Horie S, et al. (2003) Tumor necrosis factoralpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 88: 730–735\nSatoh M, Minami M (1995) Molecular pharmacology of the opioid receptors. Pharmacol Ther 68: 343–364\nSchulte-Herbruggen O, Nassenstein C, Lommatzsch M, et al. (2005) Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 160: 204–209\nSidell N, Han SW, Parthasarathy S (2002) Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 955: 159–173\nSinaii N, Plumb K, Cotton L, et al. (2007) Differences in characteristics among 1000 women with endometriosis based on extent of disease. Fertil Steril May 9 Epub\nSmith WL, Garavito RM, De Witt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and-2. J Biol Chem 271: 33157–33160\nStein C, Hassan AH, Lehrberger K, et al. (1993) Local analgesic effect of endogenous opioid peptides. Lancet 342: 21–24\nSurrey ES, Hornstein MD (2002) Prolonged GnRH agonist and addback therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 99: 709–719\nSutton JG, et al. (1997) Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril 68: 1070–1074\nSutton CJ, Ewen SP, Whitelaw N, Haines P (1994) Prospective, randomized, double blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril 62: 696–700\nSzabo I, Chen XH, Xin L, et al. (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 99: 10276–10281\nTamburro S, Canis M, Albuisson E, et al. (2003) Expression of transforming growth factor beta1in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil Steril 80: 1131–1136\nTelimaa S, et al. (1987) Placebo controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1: 13–23\nThomas EJ, Cooke ID (1987) Successful treatment of asymptomatic endometriosis: does it benefit infertile women? Br Med J 294: 1117–1119\nTokushige N, Markham R, Russell P, Fraser IS (2006) High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod 21: 782–787\nTokushige N, Markham R, Russell P, Fraser IS (2007) Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis. Fertil Steril (In press)\nVelemir L, Krief M, Matsuzaki S, et al. Physiopathologie de l’endométriose. «Quand celui qui affirme, ignore, oublie ou méprise le contraire» EMC à paraître\nVercellini P, Cortesi I, Crosignani PG (1997) Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 68: 393–401\nVercellini P, Fedele L, Aimi G, et al. (2007) Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod 22: 266–271\nVogel C, Mossner R, Gerlach M, et al. (2003) Absence of thermal hyperalgesia in serotonin transporter-deficient mice. Neurosci 23: 708–715\nWaller KG, Shaw RW (1995) Endometriosis, pelvic pain, and psychological functioning. Fertil Steril 63: 796–800\nZhao D, Lebovic DI, Taylor RN (2002) Long-term progestin treatment inhibits RANTES (regulated on activation, normal T cell expressed and secreted) gene expression in human endometrial stromal cells. J Clin Endocrinol Metab 87: 2514–2519\nZhang N, Rogers TJ, Caterina M, Oppenheim JJ (2004) Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol 173: 594–599\nAuthor information\nAuthors and Affiliations\nCorresponding author\nAbout this article\nCite this article\nCanis, M., Matsuzaki, S., Rivoire, C. et al. Endométriose et douleur. Douleur analg. 20, 141–149 (2007). https://doi.org/10.1007/s11724-007-0049-0\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s11724-007-0049-0","source_license":"CC0","license_restricted":false}